glp-1 for diabetic receptor agonists individualized treatment of type 2 diabetes mellitus GLP-1 Medications for Type 1
Description
Letters in Drug Design & Discovery
A different mechanism Petersen was also critical of how the trials measured cognitive decline
This can lead to daytime fatigue, headaches and other short-term symptoms, as well as an increased risk of cardiovascular disease, diabetes and mental health changes
This expectation was verified based on findings of this study
